Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-over Randomized Controlled Trial of Coenzyme Q10 or Nicotinamide Riboside in Chronic Kidney Disease

NCT03579693 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03579693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03579693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-over Randomized Controlled Trial of Coenzyme Q10 or Nicotinamide Riboside in Chronic Kidney Disease
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Completed
Start date
November 14, 2018
Completion date
April 26, 2021
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, frailty, sarcopenia